Original Research

Published on 20 Aug 2024

Evaluation of preprocedural statin loading on clinical outcomes in patients undergoing elective percutaneous coronary intervention

in Lipids in Cardiovascular Disease

Umit Yasar Sinan
Bengisu Keskin Meric
Nurbanu Bursa
Gkiozde Moumin
Aysem Kaya
Alev Arat Ozkan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1435989

684 views

Mini Review

Published on 15 Aug 2024

Mini-Review: Immunogenic epitopes in apolipoprotein B-100 for atheroprotective immunization

in Lipids in Cardiovascular Disease

Norbert Gerdes
Roland Klingenberg

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1448664

661 views

Review

Published on 07 Aug 2024

Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia

in Lipids in Cardiovascular Disease

Bilal Bashir
Jonathan Schofield
Paul Downie
Michael France
Darren M. Ashcroft
Alison K. Wright
Stefano Romeo
Ioanna Gouni-Berthold
Akhlaq Maan
Paul N. Durrington

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1389106

2,584 views
3 citations

Original Research

Published on 02 Aug 2024

CD36 restricts lipid-associated macrophages accumulation in white adipose tissues during atherogenesis

in Lipids in Cardiovascular Disease

Vaya Chen
Jue Zhang
Jackie Chang
Mirza Ahmar Beg
Lance Vick
Dandan Wang
Ankan Gupta
Yaxin Wang
Ziyu Zhang
Wen Dai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1436865

2,103 views

Original Research

Published on 26 Jul 2024

Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levels

in Lipids in Cardiovascular Disease

Antti Jokiniitty
Markku Eskola
Saara Metso
Martin Bogsrud
Heini Huhtala
Tanja Saarela

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1433042

919 views

Original Research

Published on 25 Jul 2024

Association between homocysteine levels and hyperlipidemia prevalence as well as all-cause mortality of hyperlipidemia patients in the US population: results from NHANES database

in Lipids in Cardiovascular Disease

Jia Wei
Qiang Yang
Xiaofang Wang
Xin He
Wenjing Zhu
Lin Lin
Chang Liu
Canzhan Zhu
Mingjuan Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1419579

1,407 views

Correction

Published on 18 Jul 2024

Corrigendum: Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease

in Lipids in Cardiovascular Disease

Ji Cui
Qilong Zhai
Mengjie Chen
Zhu Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1439868

640 views

Original Research

Published on 17 Jul 2024

Enhanced atherosclerosis in apolipoprotein E knockout rabbits: role of apoB48-rich remnant lipoproteins

in Lipids in Cardiovascular Disease

Manabu Niimi
Yajie Chen
Huanyu Zhao
Xiangming Tang
Fumikazu Matsuhisa
Huanjin Zhou
Haizhao Yan
Lu Chen
Shuji Kitajima
Akira Sato

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1424064

1,155 views

Systematic Review

Published on 11 Jul 2024

Traditional Chinese medicine lowering lipid levels and cardiovascular events across baseline lipid levels among coronary heart disease: a meta-analysis of randomized controlled trials

in Lipids in Cardiovascular Disease

Lihua Xie
Jia Liu
Xiaochi Wang
Birong Liu
Jiaqi Li
Jingen Li
Huanlin Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1407536

1,266 views

Original Research

Published on 10 Jul 2024

Adherence to the 2018 AHA cholesterol management guideline in hyperlipidemia treatment among adults in an outpatient setting

in Lipids in Cardiovascular Disease

Bahere Behdani
Toba Kazemi
Mahmood Zardast
Saeede Khosravi Bizhaem
Shima Jafari

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1340311

1,242 views

Brief Research Report

Published on 09 Jul 2024

Trends and findings of lipoprotein(a) testing and associated cardiovascular disease profiles: a large single-center study from the Middle East-Gulf region

in Lipids in Cardiovascular Disease

Yosef Manla
Laila AbdelWareth
Ronney Shantouf
Yazan Aljabery
Terrence Lee St John
Hani Sabbour
Bartlomiej Piechowski-Jozwiak
Wael Almahmeed

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1439013

1,654 views

Review

Published on 25 Jun 2024

PCSK9 inhibition: from effectiveness to cost-effectiveness

in Lipids in Cardiovascular Disease

Iveta Mercep
Dominik Strikic
Pero Hrabac
Ivan Pecin
Željko Reiner

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1339487

2,009 views
1 citation

Original Research

Published on 30 Apr 2024

Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease

in Lipids in Cardiovascular Disease

Ji Cui
Qilong Zhai
Mengjie Chen
Zhu Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1401010

1,608 views
1 citation

Review

Published on 04 Apr 2024

Biomechanics-mediated endocytosis in atherosclerosis

in Lipids in Cardiovascular Disease

Jinxuan Wang
Jianxiong Xu
Tianhu Liu
Chaoping Yu
Fengcheng Xu
Guixue Wang
Shun Li
Xiaozhen Dai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1337679

1,998 views

Original Research

Published on 25 Mar 2024

The impact of dyslipidemia on prognosis of patients after endovascular abdominal aortic aneurysm repair

in Lipids in Cardiovascular Disease

Xin Luo
Qiang Guo
Jiarong Wang
Yiyuan Li
Jichun Zhao
Bin Huang
Xiyang Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1341663

1,198 views

Case Report

Published on 12 Mar 2024

Case Report: Neurological adverse events in subject with myasthenia gravis after PCSK9 inhibitor administration

in Lipids in Cardiovascular Disease

Věra Adámková
Martina Vitásková
Jaroslav A. Hubáček

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1343775

2,108 views
1 citation

Navigation group

Articles

Evaluation of preprocedural statin loading on clinical outcomes in patients undergoing elective percutaneous coronary intervention

Mini-Review: Immunogenic epitopes in apolipoprotein B-100 for atheroprotective immunization

Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia

CD36 restricts lipid-associated macrophages accumulation in white adipose tissues during atherogenesis

Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levels

Association between homocysteine levels and hyperlipidemia prevalence as well as all-cause mortality of hyperlipidemia patients in the US population: results from NHANES database

Corrigendum: Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease

Enhanced atherosclerosis in apolipoprotein E knockout rabbits: role of apoB48-rich remnant lipoproteins

Traditional Chinese medicine lowering lipid levels and cardiovascular events across baseline lipid levels among coronary heart disease: a meta-analysis of randomized controlled trials

Adherence to the 2018 AHA cholesterol management guideline in hyperlipidemia treatment among adults in an outpatient setting

Trends and findings of lipoprotein(a) testing and associated cardiovascular disease profiles: a large single-center study from the Middle East-Gulf region

PCSK9 inhibition: from effectiveness to cost-effectiveness

Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease

Biomechanics-mediated endocytosis in atherosclerosis

The impact of dyslipidemia on prognosis of patients after endovascular abdominal aortic aneurysm repair

Case Report: Neurological adverse events in subject with myasthenia gravis after PCSK9 inhibitor administration